April 20 (Reuters) - UK's Competition and Markets Authority:
- CMA: PROVISIONALLY FINDS HEARING IMPLANTS COCHLEAR LIMITED / OTICON MEDICAL MERGER COULD SUBSTANTIALLY REDUCE COMPETITION
- CMA: COCHLEAR LIMITED / OTICON MEDICAL MERGER COULD POTENTIALLY LEAD TO WORSE OUTCOMES FOR PATIENTS AND HIGHER COSTS FOR NHS
- CMA: DURING NEXT STAGE OF ITS INVESTIGATION, CMA WILL CONSIDER POTENTIAL REMEDIES FOR ITS CONCERNS ON COCHLEAR LIMITED / OTICON MEDICAL DEAL
April 20 (Reuters) - UK's Competition and Markets Authority:...
Add to My Watchlist
What is My Watchlist?